📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Embark Biotech

1.1 - Company Overview

Embark Biotech Logo

Embark Biotech

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotech research identifying novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake; founded in 2017 and headquartered in Copenhagen, Denmark.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Embark Biotech

89bio Logo

89bio

HQ: United States Website
  • Description: Provider of biologic and small molecule therapies for liver and metabolic disorders, developing pegozafermin for MASH to reduce liver fibrosis and for severe hypertriglyceridemia to lower triglyceride levels and address lipid metabolism imbalance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 89bio company profile →
Affymax Logo

Affymax

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affymax company profile →
Ocera Therapeutics Logo

Ocera Therapeutics

HQ: United States Website
  • Description: Provider of novel therapeutics in development for patients with acute and chronic liver disease, as a clinical-stage biopharmaceutical company focused on development and commercialization in an area of high unmet medical need; HE clinical development includes a recently completed Phase 2b trial, STOP-HE, which evaluated safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ocera Therapeutics company profile →
Ysopia Bioscience Logo

Ysopia Bioscience

HQ: France Website
  • Description: Provider of cutting-edge microbiome-based biotherapies in clinical-stage development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ysopia Bioscience company profile →
ViaCyte Logo

ViaCyte

HQ: United States Website
  • Description: Provider of preclinical regenerative medicine therapies for diabetes, based on differentiation of stem cells into pancreatic beta-cell precursors implanted subcutaneously in an encapsulation device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ViaCyte company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Embark Biotech

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Embark Biotech

2.2 - Growth funds investing in similar companies to Embark Biotech

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Embark Biotech

4.2 - Public trading comparable groups for Embark Biotech

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Embark Biotech

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Embark Biotech

What does Embark Biotech do?

Embark Biotech is a provider of biotech research identifying novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake; founded in 2017 and headquartered in Copenhagen, Denmark.

Who are Embark Biotech's competitors?

Embark Biotech's competitors and similar companies include 89bio, Affymax, Ocera Therapeutics, Ysopia Bioscience, and ViaCyte.

Where is Embark Biotech headquartered?

Embark Biotech is headquartered in Denmark.

How many employees does Embark Biotech have?

Embark Biotech has 1,000 employees 🔒.

When was Embark Biotech founded?

Embark Biotech was founded in 2010 🔒.

What sector and industry vertical is Embark Biotech in?

Embark Biotech is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Embark Biotech

Who are the top strategic acquirers in Embark Biotech's sector and industry

Top strategic M&A buyers and acquirers in Embark Biotech's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Embark Biotech?

Top strategic M&A buyers groups and sectors for Embark Biotech include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Embark Biotech's sector and industry vertical

Which are the top PE firms investing in Embark Biotech's sector and industry vertical?

Top PE firms investing in Embark Biotech's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Embark Biotech's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Embark Biotech's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Embark Biotech's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Embark Biotech include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Embark Biotech's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Embark Biotech?

The key public trading comparables and valuation benchmarks for Embark Biotech include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Embark Biotech for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Embark Biotech with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Embark Biotech's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Embark Biotech with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Embark Biotech's' sector and industry vertical?

Access recent funding rounds and capital raises in Embark Biotech's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Embark Biotech